World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
59
Citations
27397
World Ranking
12251
National Ranking
5237

Overview

Luigi Franchi is affiliated with the University of Michigan-Ann Arbor in the United States. Their research spans multiple areas within medicine and the biological sciences, with a substantial focus on molecular and genetic aspects of immunology and disease mechanisms.

The primary fields of study associated with Luigi Franchi include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these domains, the scientist's work extends into several subfields, notably:

  • Genetics
  • Immunology
  • Molecular Biology
  • Epidemiology
  • Cancer Research

Key topics commonly addressed in their research involve:

  • Inflammasome and immune disorders
  • Virus-based gene therapy research
  • Eosinophilic Esophagitis
  • Glioma Diagnosis and Treatment
  • Cancer, Hypoxia, and Metabolism
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses

Luigi Franchi has contributed to a range of scientific publications across several reputable journals. Frequent publication venues include:

  • Journal of Medicinal Chemistry
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Science Immunology
  • Frontiers in Molecular Biosciences
  • Journal of Crohn's and Colitis

Selected recent publications demonstrate the scope of Luigi Franchi's work:

  • OXPHOS promotes apoptotic resistance and cellular persistence in T H 17 cells in the periphery and tumor microenvironment, 2022, Science Immunology
  • The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis, 2021, Frontiers in Molecular Biosciences
  • Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor, 2025, Journal of Medicinal Chemistry
  • NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases, 2023, Journal of Crohn's and Colitis
  • Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma, 2024, Nature Communications

Collaborations are a notable aspect of Luigi Franchi's research efforts. Frequent co-authors include:

  • Anthony W. Opipari
  • Nneka E. Mbah
  • Hanna S. Hong
  • Mengrou Shan
  • Peter Sajjakulnukit

Best Publications

  • NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

    Peter Duewell;Hajime Kono;Katey J. Rayner;Katey J. Rayner;Cherilyn M. Sirois

  • The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis.

    Luigi Franchi;Tatjana Eigenbrod;Raúl Muñoz-Planillo;Gabriel Nuñez

  • Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

    Seth L Masters;Aisling Dunne;Shoba L Subramanian;Rebecca L Hull

  • Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages

    Luigi Franchi;Amal Amer;Mathilde Body-Malapel;Thirumala Devi Kanneganti

  • Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3

    Thirumala Devi Kanneganti;Nesrin Özören;Mathilde Body-Malapel;Amal Amer

  • Sensing and reacting to microbes through the inflammasomes

    Luigi Franchi;Raul Muñoz-Planillo;Gabriel Núñez

  • Function of Nod-like receptors in microbial recognition and host defense.

    Luigi Franchi;Neil Warner;Kyle Viani;Gabriel Nuñez

  • Critical Role for Cryopyrin/Nalp3 in Activation of Caspase-1 in Response to Viral Infection and Double-stranded RNA

    Thirumala Devi Kanneganti;Mathilde Body-Malapel;Amal Amer;Jong Hwan Park

  • Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages.

    Toshihiko Suzuki;Luigi Franchi;Claudia Toma;Hiroshi Ashida

  • Cutting Edge: TNF-α Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation

    Luigi Franchi;Tatjana Eigenbrod;Gabriel Núñez

  • Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome

    Franz Bauernfeind;Eva Bartok;Anna Rieger;Luigi Franchi

  • Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages

    Yan Qu;Luigi Franchi;Gabriel Nunez;George R. Dubyak

  • Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling.

    Thirumala Devi Kanneganti;Mohamed Lamkanfi;Yun Gi Kim;Grace Chen

  • The Nlrp3 inflammasome is critical for aluminium hydroxide‐mediated IL‐1β secretion but dispensable for adjuvant activity

    Luigi Franchi;Gabriel Núñez

  • Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf.

    Amal Amer;Luigi Franchi;Thirumala Devi Kanneganti;Mathilde Body-Malapel

  • NLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defense.

    Luigi Franchi;Nobuhiko Kamada;Yuumi Nakamura;Aaron Burberry

  • Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria.

    Luigi Franchi;Thirumala Devi Kanneganti;George R. Dubyak;Gabriel Núñez

  • A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome.

    Raúl Muñoz-Planillo;Luigi Franchi;Lloyd S. Miller;Gabriel Núñez

  • The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands.

    Yun Gi Kim;Jong Hwan Park;Michael H. Shaw;Luigi Franchi

  • Erratum: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals (Nature (2010) 464 (1357-1361))

    Peter Duewell;Hajime Kono;Katey J. Rayner;Cherilyn M. Sirois

Frequent Co-Authors

Gabriel Núñez
Gabriel Núñez University of Michigan–Ann Arbor
Thirumala-Devi Kanneganti
Thirumala-Devi Kanneganti St. Jude Children's Research Hospital
Shizuo Akira
Shizuo Akira Osaka University
George R. Dubyak
George R. Dubyak Case Western Reserve University
Naohiro Inohara
Naohiro Inohara University of Michigan–Ann Arbor
Peter Vandenabeele
Peter Vandenabeele Ghent University
Kathryn J. Moore
Kathryn J. Moore New York University Langone Medical Center
John Bertin
John Bertin GlaxoSmithKline (United Kingdom)
Veit Hornung
Veit Hornung Ludwig-Maximilians-Universität München
Katherine A. Fitzgerald
Katherine A. Fitzgerald University of Massachusetts Chan Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Luigi Franchi

Trending Scientists

Recently Published Articles